The FDA is taking action to close longstanding gaps in how gluten-containing ingredients are disclosed on food labels, with direct implications for children and families living with celiac disease or gluten sensitivity.
On January 21, 2026, the agency issued a Request for Information seeking public input on gluten labeling practices and cross-contact prevention in packaged foods. The move signals growing federal attention to one of the most common autoimmune conditions affecting children today. Celiac disease impacts approximately 1 in 100 people worldwide, and for those diagnosed, even trace amounts of gluten can trigger serious gastrointestinal and immune responses, including abdominal pain, bloating, diarrhea, and longer-term damage to the small intestine if left unmanaged.
The problem the FDA is trying to solve is a longstanding one. While existing labeling rules require wheat to be declared on food packaging, other gluten-containing grains like rye, barley, and oats that have been exposed to cross-contact during manufacturing have not always been clearly identified on labels. That gap has left countless families in a frustrating guessing game every time they walk down the grocery aisle, trying to determine whether a product is truly safe for their child to eat.
The Request for Information focuses on two specific areas of concern. The first involves adverse reactions linked to non-wheat gluten-containing grains that are not always easy to spot on a label. The second addresses the broader labeling gaps that make it difficult for consumers, especially parents of young children, to make fully informed purchasing decisions. The agency is also collecting data on cross-contact risks during manufacturing, where products labeled gluten-free may be inadvertently contaminated before they ever reach store shelves.
The information gathered through this public comment process will directly shape the FDA’s next regulatory steps. While a formal rule change could still be some time away, the fact that the agency is actively seeking input from affected communities is a meaningful signal that stronger protections are on the horizon.
In the meantime, the practical guidance for families has not changed. Work closely with your child’s pediatrician or a registered dietitian to develop safe eating strategies, keep a close eye on ingredient lists even for familiar products, and stay informed as the FDA’s process continues to develop. For families managing celiac disease in a child, having a trusted pediatric provider in your corner, someone who knows your child’s history and can help you navigate both the medical and dietary side of this condition, makes all the difference.
References / Sources
- U.S. Food and Drug Administration. FDA Takes Steps to Improve Gluten Ingredient Disclosure in Foods. Press Release, January 21, 2026. FDA.gov.
- Celiac Disease Foundation. What Is Celiac Disease? Celiac.org.
American Academy of Pediatrics (AAP). Celiac Disease in Children. HealthyChildren.org.
